# Brooks Laboratories Ltd (BROOKS)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹56.41
Day Change: +4.99%
52W High: ₹165.95
52W Low: ₹36.9
Market Cap: ₹138 Cr

## Valuation
P/E: 6.36
P/B: 1.19
EPS: ₹7.35
Book Value: ₹39.29
Dividend Yield: 0%

## Returns
1Y Return: -49.76%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0.07
Revenue Growth: -56.9%
Profit Growth: 0%
EBITDA Margin: 8.78%
Operating Margin: 2.05%

## About
Brooks Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Brooks Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Update On Scheme Of Arrangement Involving Brooks Steriscience Limited ('BSL'), A Joint Venture / Associate Of The Company.
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Update On Scheme Of Arrangement Involving Brooks Steriscience Limited ('BSL'), A Joint Venture / Associate Of The Company.

## Access
Current tier: anonymous
More history: Register free to see 2 more years.

## Data Freshness
Quote Updated: 2026-05-25T18:00:11.510Z
Price History Updated: 2026-05-25T05:26:24.639Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:26:24.639Z
Quant Updated: 2026-05-25T05:26:24.639Z
Sentiment Updated: 2026-05-25T05:26:24.639Z
Financials Status: current
Financials Updated: 2026-05-18T23:05:06.275Z
Financials Last Attempt: 2026-05-18T23:05:06.275Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2022)
Revenue: ₹77 Cr
Operating Profit: ₹1 Cr (OPM 1%)
Net Profit: ₹-19 Cr
Tax: ₹-9 Cr

## Annual P&L History
Mar 2022: Rev ₹77Cr | PAT ₹-19Cr | OPM 1%
Mar 2023: Rev ₹91Cr | PAT ₹-19Cr | OPM -16%
Mar 2024: Rev ₹63Cr | PAT ₹-31Cr | OPM -47%

## Balance Sheet (Mar 2022)
Total Assets: ₹162 Cr
Total Liabilities: ₹162 Cr
Borrowings: ₹31 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Prashant  Rathi, Chief Financial Officer
- Krutika Mohan Rane, Company Secretary & Compliance Officer
- Durga Shankar Maity M.Sc., Whole Time Director
- Atul  Ranchal PGDFMT, President of Corporate Strategy
- Jitendra Pratap Singh, Whole Time Director

---
Source: rupiya.io/stocks/brooks
Disclaimer: For research and education only. Not investment advice.